The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

M Gearing, SS Mirra, JC Hedreen, SM Sumi… - Neurology, 1995 - AAN Enterprises
Article abstract-This report summarizes the neuropathologic findings in the first 106
autopsies of CERAD (Consortium to Establish a Registry for Alzheimer's Disease) dementia …

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

SS Mirra, A Heyman, D McKeel, SM Sumi, BJ Crain… - Neurology, 1991 - AAN Enterprises
The Neuropathology Task Force of the Consortium to Establish a Registry for Alzheimer's
Disease (CERAD) has developed a practical and standardized neuropathology protocol for …

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

JC Morris, A Heyman, RC Mohs, JP Hughes… - Neurology, 1989 - europepmc.org
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed
brief, comprehensive, and reliable batteries of clinical and neuropsychological tests for …

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years

GG Fillenbaum, G van Belle, JC Morris, RC Mohs… - Alzheimer's & …, 2008 - Elsevier
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) was funded by the
National Institute on Aging in 1986 to develop standardized, validated measures for the …

The consortium to establish a registry for alzheimer's disease (CERAD) part IX. A prospective cliniconeuropathologic study of Parkinson's features in alzheimer's …

C Hulette, S Mirra, W Wilkinson, A Heyman… - Neurology, 1995 - AAN Enterprises
Although extrapyramidal signs such as rigidity, bradykinesia, and postural impairment
frequently occur in patients with Alzheimer's disease (AD), the correlation of these …

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

D Galasko, SD Edland, JC Morris, C Clark, R Mohs… - Neurology, 1995 - AAN Enterprises
The rate of cognitive decline, measured by psychometric testing, is widely used to track the
progression of Alzheimer's disease (AD). As an alternative approach, we studied clinical …

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic …

GM McKhann, DS Knopman, H Chertkow… - Alzheimer's & …, 2011 - Elsevier
The National Institute on Aging and the Alzheimer's Association charged a workgroup with
the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup …

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

A Heyman, RC Mohs, JP Hughes, G Van Belle… - Neurology, 1989 - AAN Enterprises
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed
brief, comprehensive, and reliable batteries of clinical and neuropsychological tests for …

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

CR Jack Jr, JS Andrews, TG Beach… - Alzheimer's & …, 2024 - Wiley Online Library
Abstract The National Institute on Aging and the Alzheimer's Association convened three
separate work groups in 2011 and single work groups in 2012 and 2018 to create …

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery

KA Welsh, N Butters, RC Mohs, D Beekly, S Edland… - Neurology, 1994 - AAN Enterprises
The neuropsychological tests developed for the Consortium to Establish a Registry for
Alzheimer's Disease (CERAD) are currently used to measure cognitive impairments of …